Medical and Pharmaceutical Roche collaboration to accelerate Freenome’s blood-based cancer screening The companies intend to work jointly on improving Freenome’s cell-free DNA cancer tests Joseph Morton5 days ago
Medical and Pharmaceutical Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects Abbott earned billions during the Covid-19 pandemic by selling millions of Covid tests and testing kits Joseph MortonNovember 20, 2025
Medical and Pharmaceutical California kids create US$200 breath analyzer for lung diseases Losing a family member was a key source of inspiration for one of the inventors Rowan DunneOctober 29, 2025
Medical and Pharmaceutical SmartPath Uses AI to personalize cancer care across Asia SmartPath was trained using over 500,000 whole slide images covering 34 major tissue sites Joseph MortonOctober 23, 2025
Medical and Pharmaceutical Galleri shows promise in large U.S. based clinical trial Researchers believe this approach could allow doctors to catch cancers much earlier Joseph MortonOctober 20, 2025
Medical and Pharmaceutical Leading experts exchange lung cancer insights at Vietnam conference Biomarker testing, AI and early detection were key topics this year Rowan DunneOctober 14, 2025
Medical and Pharmaceutical Five new radical frontiers of cancer detection: a Mugglehead roundup Spider silk, smart tattoos, and nanoparticles are giving doctors safer, faster ways to detect lung cancer Joseph MortonOctober 10, 2025
Medical and Pharmaceutical Owlstone Medical gets up to US$49.1M to develop multi-cancer breath tests Urine samples will also be examined to detect various solid tumours Rowan DunneOctober 7, 2025
Medical and Pharmaceutical University of Bath spinout tests real-time lung biopsy device A lung biopsy can confirm a diagnosis in the laboratory and reveal the molecular structure of a lesion Joseph MortonSeptember 17, 2025
Medical and Pharmaceutical AI-powered lung cancer detection debuts at Topeka’s St. Francis Hospital The program aims to prevent overlooked findings, surface patients who need additional review, and support long-term monitoring Joseph MortonSeptember 10, 2025